All filters
Slidesets
O_20: Evaluation of Drug-Drug Interactions between Sofosbuvir/Velpatasvir/Voxilaprevir and Boosted or Unboosted HIV Antiretroviral Regimens- Kimberly Garrison
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_21: The Potential Role of PK-Based Drug Interactions in FAERS-Reported Rhabdomyolysis Cases in Patients Receiving a DAA Regimen and a Statin- Su-Young Choi, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Pro Standpoint- Nancy Reau, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Con Standpoint- Jürgen Rockstroh, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Janssen: Influenza- Thomas Kakuda, PharmD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Gilead: RSV - Erik Mogalian
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Merck: CMV - Cyrus Badshah, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Meeting
APACC 2017
1 Jun 2017 - 3 Jun 2017
Hong Kong
Slidesets
Program implementer perspective- Fujie Zhang, MD, PhD
Presented at:
APACC 2017
Slidesets
Community Perspective- Martin Choo, MMedSc
Presented at:
APACC 2017
Slidesets
The SWORD study- Chien-Ching Hung, MD, PhD
Presented at:
APACC 2017
Slidesets
Neurocognitive issues among aging adults- Edwina Wright
Presented at:
APACC 2017